Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
The British Journal of Diabetes & Vascular Disease
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Jarvis, S.
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Editorial

Self-monitoring of blood glucose: is it worth it?

Sarah Jarvis

Richford Gate Medical Practice, Richford Street, London, W6 7HY, UK? sarah.jarvis{at}gp-E85016.nhs.uk

References

  • Alberti G. Tight glycaemic control: the key to improving the management of type 2 diabetes. Br J Diabetes Vasc Dis 2005;5:184-5.[Free Full Text]
  • MeReC bulletin. When and how should patients with diabetes mellitus test blood glucose? 2002;13:1-4.
  • Diabetes UK 2004, www.diabetes.org.uk accessed 5/5/05.
  • Bottomley JM on behalf of the T2ARDIS steering group committee and UK centres. Learning from T2ARDIS. Br J Diabetes Vasc Dis 2001;1:68-72.[Abstract/Free Full Text]
  • Stratton IM, Adler AI, Neil HAW et al, on behalf of the UK Prospective Diabetes Study Group. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000;321:405-12.[Abstract/Free Full Text]
  • National Prescribing Centre 2001. www.npc.co.uk accessed 5/5/05.
  • National Diabetes Support team 2003. www.cgsupport.nhs.uk accessed
  • Coster S., Gulliford MC, Seed PT, Powriet JK, Swaminathan R. Self-monitoring in type 2 diabetes mellitus: a meta-analysis. Diabet Med 2000;17: 755-61.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Schwedes U., Siebolds M., Mertes G. et al. Meal-related structured selfmonitoring of blood glucose. Effect on diabetes control in non-insulintreated type 2 diabetic patients. Diabetes Care 2002;25:1928-32.[Abstract/Free Full Text]
  • International Diabetes Federation 2005. Clinical Guidelines Task Force, Global Guidelines for type 2 diabetes. 2005;chapter 8 (self-monitoring) www.idf.org
  • Guerci B., Drouin P., Grange V. et al. Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study. Diabetes Metab 2003;29:587-94.[Web of Science][Medline] [Order article via Infotrieve]
  • Nice 2002. Inherited clinical Guideline G. Management of type 2 diabetes: management of blood glucose. www.nice.org.uk accessed 5/5/05
  • American Diabetes Association. Standards of Medical Care in Diabetes. Diabetes Care 2005;28(suppl 1):54-5.
  • Diabetes Control and Complications Trial research group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New Eng J Med 1993;329:977-86.[Abstract/Free Full Text]
  • UK Prospective Diabetes Study group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Department of Health. NSF for diabetes, 2001 www.dh.gov.uk/PolicyAndGuidance/HealthAndSocialCareTopics/Diabetes accessed 5/5/05.
  • Emslie-Smith A., Dowall J., Morris A. The problem of polypharmacy in type 2 diabetes. Br J Diabetes Vasc Dis 2003;3:54-5.[Abstract/Free Full Text]

The British Journal of Diabetes & Vascular Disease, Vol. 5, No. 5, 245-246 (2005)
DOI: 10.1177/14746514050050050101


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Jarvis, S.
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?